Parkinson's UK has allocated more than 200,000 pounds for virtual biotechnology

The Parkinson's Foundation, in partnership with the Parkinson's Foundation in the UK, has invested more than 200,000 pounds in the charity's virtual biotech company.
Funding from the U.S.-based organization will support a project that seeks to find new ways to prevent brain cell death by stabilizing the source of energy necessary for cell survival, mitochondrials.The partnership marks Parkinson's UK's first international grant for Parkinson's Virtual Biotechnology and marks "the beginning of a joint transatlantic mission to quickly track the best scientific ideas and provide breakthrough new treatments for Parkinson's disease."Every year, people with Parkinson's disease in the UK, their supporters and partners invest more than 4 million pounds in the Parkinson's Virtual Biotechnology Project to rapidly develop and test the most promising research results, with the aim of transforming them into treatments that can change the lives of people with Parkinson's disease. The virtual biotechnology project "focuses on the most important projects for the Parkinson's community" and is driven by collaboration with the world's leading research organizations that are best placed to achieve the goals of each project.
John Lear, the organisation's president and chief executive, said the foundation was "delighted to work with people with Parkinson's disease in the UK to advance innovative research that will contribute to the international parkinson's community."
He continued, "This collaboration will help us better serve people with Parkinson's disease today, while promoting hope for future cures."also announced that they would work together on a campaign and fundraiser called the Parkinson's Revolution, an indoor cycling experience that will take place in the United States, Canada and the United Kingdom on 8 February 2020 to raise awareness and raise funds for Parkinson's research and projects. （cyy123.com）